Health Care/Hospital
ZEISS at the 2020 Virtual ESCRS & EURETINA Congress
ZEISS Introduces New Solution Enhancements for Procedure Workflows at ESCRS and EURETINA JENA, Germany, Oct. 2, 2020 /PRNewswire/ -- ZEISS presents its new solution enhancements to help doctors maximize clinical efficiency and improve patient care - from assessment, diagnosis, to treatment. The ...
Happiness Biotech Announced Receipt of FDA Registration For Its Hand Sanitizer
NANPING, China, Oct. 1, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company's hand sanitizer products have been registered with U.S. Food and Drug Administra...
Technopath Clinical Diagnostics Introduces the First Unified, Purpose-Built Quality-Control (QC) Platform Providing a Higher Level of Confidence in the Precision and Accuracy of Patient Sample Results
IAMQC Infinity™ is the first Software-as-a-Service (SaaS) platform for clinical laboratories to bring together worldwide peer comparisons, advanced QC analytics, proficiency testing data, and daily QC data management functions in real-time on one unified platform IAMQC Infinity empowers frontlin...
Growing Global Demand for ESP Disc Replacements Leads to Formation of Independent Company -- Spine Innovations to Launch October 1
HEIMSBRUNN, France, Oct. 1, 2020 /PRNewswire/ -- The growing global demand for ESP disc replacements has led to the creation of an independent company called Spine Innovations, scheduled to launch onOctober 1, 2020. The new company will take over the entire spine business of its parent company FH...
Concord Medical Announces a Hoisting Ceremony for the Proton Therapy System of Guangzhou Concord Cancer Center
BEIJING, Sept. 30, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone...
GVN's Top Virus Experts Meet Together To Identify Most Promising Advances To Battle COVID-19 & Strategies To Prepare For Future Pandemics
BALTIMORE, Oct. 1, 2020 /PRNewswire/ -- The Global Virus Network (GVN), a coalition of the world's leading medical and basic virology research centers working to prevent illness and death from viral disease, convened a press conference with attendees from across the globe to discuss key takeaways...
Turning AI onto itself: AI algorithm detects when medical images will be difficult for radiologists or AI to make an effective diagnosis
SAN FRANCISCO, Sept. 30, 2020 /PRNewswire/ -- A new AI algorithm can identify when medical images are likely to be difficult for either a radiologist or AI to make an effective diagnosis. The algorithm can potentially be used to triage medical scans and highlight cases that warrant further in-dep...
Harbour BioMed Announces Dosing of First Patients in Two Phase II Clinical Studies of Batoclimab (HBM9161) for the Treatment of Myasthenia Gravis and Immune Thrombocytopenia
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 30, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, bio-pharmaceutical company announced today the dosing of the first patient in two separate Phase II clinical trials of Batoclimab (HBM 9161), a fully human...
OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNA
TOKYO, Sept. 30, 2020 /PRNewswire/ -- OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gene therapy and synthetic biology, has today launched the OriCiroTM Cell-Free Cloning System, the world's first technology enabling cell-free amplification...
Independent multi-center trial shows that Getinge's NAVA ventilation mode shortens time of mechanical ventilation by almost 35% for adult ICU patients
GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- The clinical effectiveness of Getinge's patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient's own respiratory drive to control ventilator assistance, is supported in the NAVIATOR trial. According to the NAVIATOR trial, N...
Firmenich Opens New Era in Ingredient Creation with Launch of Biotech and Naturals Pilot Plant in Geneva
GENEVA, Switzerland, Sept. 30, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned Perfume and Taste company, is proud to announce the opening of its new biotechnology and naturals pilot plant and laboratory in Geneva. Benefiting from the latest digital technology, the facility ope...
MARii and Sengenics Launch ImmuSAFE® - World's First Multi-Antigen, Epitope Specific, Fully Quantitative COVID-19 Test
CYBERJAYA, Malaysia, Sept. 30, 2020 /PRNewswire/ -- The Malaysia Automotive,
Robotics and IoT Institute (MARii) and Sengenics Sdn. Bhd. launched the
ImmuSAFE COVID+ biochip, at MARii's headquarters, Cyberjaya.
I-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency
SHANGHAI and GAITHERSBURG, Md., Sept. 30, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the China Center for Drug Evaluation (CDE) has app...
The 11th China (Taizhou) International Medical Expo ended successfully
NANJING, China, Sept. 30, 2020 /PRNewswire/ -- From September 19 to 21, the 11th China (Taizhou) International Medical Expo was held at the China Medical City Exhibition Center. With the theme of "Development Trends in the Medical and Health Industry under the Epidemic", the current medical expo h...
111, Inc. Builds Digitally-enabled, Omni-channel Drug Commercialization Platform as Part of its Goal to Provide Full Life-cycle Healthcare Management Solutions for Patients
SHANGHAI, Sept. 30, 2020 /PRNewswire/ -- On September 24, 2020, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services inChina, hosted its 3rd annual China Online Healthcare Summit and P...
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand
TAIPEI, Sept. 30, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen")(Taiwan: 4157) today announced that they have signed an exclusive licensing agreement with Luminarie Canada Inc. ("Luminarie"), a leading Canadian pharmaceutical company, to develop and commercialize Taigexyn® ...
Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company's AKVANO® technology
STOCKHOLM, Sept. 30, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North:LIPI) today announces a positive outcome of the feasibility study into the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The study was conducted in collabor...
HeyGears Announces its Latest Innovations in Digital Manufacturing Solutions: A Clear Aligner Production Solution and UltraCraft A2D 4K
GUANGZHOU, China, Sept. 30, 2020 /PRNewswire/ -- At Dental South China International Expo, HeyGears announces two of its latest innovations in digital manufacturing solutions. First, HeyGears' clear aligner production solution that allows 24/7 mass production of clear aligner models and digitally...
Statement from Bill & Melinda Gates Foundation CEO Mark Suzman on Momentum in Global COVID-19 Response
SEATTLE, Sept. 30, 2020 /PRNewswire/ -- The death toll from COVID-19 passed one million this week. It is a sobering moment. But there is cause for optimism as recent days have seen a significant surge in momentum around global cooperation, which is our greatest strength when it comes to consignin...
BioGX launches CE-IVD Marked COVID-19, Influenza A/B, RSV Combo RT-PCR Test for the BD MAX™ System
AMSTERDAM, Sept. 30, 2020 /PRNewswire/ -- BioGX BV, the European subsidiary of Birmingham, Alabama based BioGX, announced availability of a CE-IVD marked test for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus RNA in a patient sample using the BD MA...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 257 media titles]
2024-05-02 01:21Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 251 media titles]
2024-04-30 15:13